JPRN-UMIN000012574已完成未知
An open-label study evaluating the effectiveness of aripiprazole for schizophrenia patients with dopamine supersensitivity psychosis. - Alpha-PROGRESS trial
Department of Psychiatry, Chiba University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2013年12月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Under treatment with clozapine 2)A treatment history of ECT in the 3 months prior to the study enrollment 3)In a coma state 4)Under profound effects by CNS inhibition drugs such as barbiturates or anesthetic agent 5)Under treatment with adrenergic agent 6)Hypersensitivity to any content in the trial drug 7)Lacking notification of diagnosis 8)Presence of any other Axis 1 or 2 psychiatric disorder according to DSM-4-TR 9)Pregnant or suspected of pregnancy 10)Participation history of a clinical trial with any intervention (i.e., except for observational study), within recent 3 months prior to the study enrollment 11)With suicide history within the 1 year proor to the study enrollment 12)Assessment as unsuitable for participation in the study by the study physician
研究者
相似试验
已完成
不适用
Pain Reduction in Osteoarthritis of the knee using oral MethotrexateOsteoarthritis of the kneeMusculoskeletal DiseasesOsteoarthritisISRCTN66676866niversity of Leeds (UK)30
进行中（未招募）
不适用
An open label study to assess the effectiveness of oral methotrexate in reducing pain in knee osteoarthritis - Pain Reduction in Osteoarthritis using oral MethotrexateEUCTR2008-008237-11-GBniversity of Leeds
招募中
2 期
An Open labeled study in efficacy of add-on Ayurveda intervention in comparison with standard in Covid-19 patients with moderate severity and with type 2 diabetes followed by 60 day follwo-upCTRI/2020/12/029985AVP Research Foundation
招募中
1 期
Open-label, prospective study evaluating the efficacy and safety of Tirbanibulin 1% (Klisyri®) in the treatment of superficial basal cell carcinomaCTIS2023-505971-66-00Centre Hospitalier Universitaire De Nice55
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Patients With Relapsing Remitting Multiple SclerosisRelapsing remitting multiple sclerosis (RRMS)MedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10048393Term: Multiple sclerosis relapseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: LLTClassification code 10039720Term: Sclerosis multipleSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-005597-38-DKF. Hoffmann-La Roche Ltd680